Michael Koenigsmann

6.2k citations
69 papers · 4.5k · 3 hit papers · h-index 25

Impact in

Papers in

    • Acute Myeloid Leukemia Research 9
    • Hematopoietic Stem Cell Transplantation 5
    • Myeloproliferative Neoplasms: Diagnosis and Treatment 6

Michael Koenigsmann

67 papers receiving 4.4k citations

Michael Koenigsmann's Hit Papers

Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial 2019 · 1.9k citations
1.9k0+3+6Years since publication5001k1.5k

Peers

Michael Koenigsmann
Comparison fields: 5 of 104
  • Pulmonary and Respiratory Medicine 1.9k
  • Internal Medicine 96
  • Oncology 646
  • Hematology 375
  • Surgery 970
Replace Maurizio Marangolo with:
Maurizio Marangolo Italy
Yoav H. Messinger United States
James C. Arseneau United States
Philip C. Amrein United States
Katherine Anne Thornton United States
Stephan Ariyan United States
Carlyn Rose C. Tan United States
Philip C. Hoffman United States
Rafat Abonour United States
Howard John Lim Canada
Michael Koenigsmann relative to Maurizio Marangolo Italy Maurizio Marangolo's profile →
Citations per field
00.5×5×10×15×20.6×
Maurizio Marangolo · 1×
Citations per year

Countries citing papers authored by Michael Koenigsmann

Since Specialization
Citations

This map shows the geographic impact of Michael Koenigsmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Koenigsmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Koenigsmann more than expected).

Fields of papers citing papers by Michael Koenigsmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Koenigsmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Koenigsmann. The network helps show where Michael Koenigsmann may publish in the future.

Co-authors

The 25 scholars most cited alongside Michael Koenigsmann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Michael Koenigsmann Line = papers co-authored together Michael Koenigsmann links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 69 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial
Hit paper breakdown →
20191880
2
Histopathological regression after neoadjuvant docetaxel, oxaliplatin, fluorouracil, and leucovorin versus epirubicin, cisplatin, and fluorouracil or capecitabine in patients with resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4-AIO): results from the phase 2 part of a multicentre, open-label, randomised phase 2/3 trial
Hit paper breakdown →
2016585
3
Effect of Neoadjuvant Chemotherapy Followed by Surgical Resection on Survival in Patients With Limited Metastatic Gastric or Gastroesophageal Junction Cancer
Hit paper breakdown →
2017379
4 2005144
5 1991132
6 2018103
7 201790
8
Nerve growth factor stimulates clonal growth of human lung cancer cell lines and a human glioblastoma cell line expressing high-affinity nerve growth factor binding sites involving tyrosine kinase signaling.
199567
9 200566
10 200761
11 199260
12 200460
13 199058
14 200656
15 201554
16 201451
17 199347
18 200442
19
Complete molecular remission in a patient with Philadelphia-chromosome positive acute myeloid leukemia after conventional therapy and imatinib.
200438
20 200436

About Michael Koenigsmann

Michael Koenigsmann is a scholar working on Hematology, Genetics, Oncology, Pathology and Forensic Medicine and Cancer Research, having authored 69 papers that have together received 4.5k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (9 papers), Lymphoma Diagnosis and Treatment (8 papers), Cancer survivorship and care (6 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (6 papers), Hematopoietic Stem Cell Transplantation (5 papers), Neutropenia and Cancer Infections (5 papers), Gastric Cancer Management and Outcomes (5 papers) and Pancreatic and Hepatic Oncology Research (4 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (1.9k citations), Internal Medicine (96 citations), Oncology (646 citations), Hematology (375 citations) and Surgery (970 citations). Michael Koenigsmann has collaborated with scholars based in Germany, United States and Austria. Frequent co-authors include Kathleen Jentsch‐Ullrich, Martin Mohren, James D. Griffin, SA Cannistra, Marcell U. Heim, A. Franke, Gerd Lutze, Jörg Frommer, Thomas Büchner and Wolfgang Hiddemann. Their work appears in journals such as Blood, Annals of Oncology, Leukemia Research, British Journal of Cancer and European Journal Of Haematology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact